Peter Cashin, MD, PhD, is a Residency Director and
Docentur/Associate Professor (Institute of Surgical Sciences) at the Department
of Surgical Sciences, Uppsala University. He obtained his MD at the Faculty
of Medicine, Uppsala University from 2003 to 2008 and his PhD at the Department
of Surgical Sciences, Uppsala University from 2009 to 2012. His research interests
are colorectal cancer, oxaliplatin, cytoreductive surgery, surgery, general
surgery, surgical oncology, colorectal surgery and hyperthermic intraperitoneal
chemotherapy. He is a member and responsible for the National HIPEC Registry
(Swedish National HIPEC Network), a management committee member of COST-PMP
(CA17101-European Network on Pseudomyxoma Peritonei) and a network member and
cofounder of the Nordic Network on Peritoneal Surgical Oncology.
Peter Cashin, MD, PhD, is a Residency Director and
Docentur/Associate Professor (Institute of Surgical Sciences) at the Department
of Surgical Sciences, Uppsala University. He obtained his MD at the Faculty
of Medicine, Uppsala University from 2003 to 2008 and his PhD at the Department
of Surgical Sciences, Uppsala University from 2009 to 2012. His research interests
are colorectal cancer, oxaliplatin, cytoreductive surgery, surgery, general
surgery, surgical oncology, colorectal surgery and hyperthermic intraperitoneal
chemotherapy. He is a member and responsible for the National HIPEC Registry
(Swedish National HIPEC Network), a management committee member of COST-PMP
(CA17101-European Network on Pseudomyxoma Peritonei) and a network member and
cofounder of the Nordic Network on Peritoneal Surgical Oncology.